Treatment with adenovirus-based vaccine plus N-803, OX40, GITR, and IDO inhibitor resulted in decreased immunosuppression of Tregs in the TME, and then the inhibition of tumor growth and protection from cancer cells rechallenge in 4T1 and LL2 models. Here, TNFRSF4 is linked to cancer.